📰 Published March News
Page 24 - Published March News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Published March. Real-time updates on events, politics, business and more.
July 26, 2022
RINVOQ (upadacitinib) is now approved by the European Commission for the treatment of adult patients with moderately to severely active ulcerative colitis who...
May 24, 2022
Read the latest stories and columns from staff writer Jeffrey Scott Shapiro in The Washington Times.
May 24, 2022
/PRNewswire/ -- Olympus, a global leader in designing and delivering innovative medical technology solutions, announced its support for the Centers for...
May 17, 2022
HbA1c is associated with risk for stroke in a dose-dependent manner among patients with diabetes and comorbid atrial fibrillation.
May 4, 2022
With further follow-up of MONALEESA-3, Kisqali plus fulvestrant achieved a median overall survival (OS) of more than five-and-a-half years (67.6 months) in the first-line (1L) setting for postmenopausal
May 4, 2022
Investegate announcements from NOVARTIS AG CHF0.50(REGD), New Novartis data demonstrate only Kisqali® offers more life in the first-line setting for postmenopausal HR+/HER2- advanced breast cancer patients
April 15, 2022
As ketamine is becoming an increasingly popular treatment method for depression, we speak to an MD about administering ketamine in a medical clinic.
April 15, 2022
Researchers characterized patterns of global fatigue in patients treated for breast cancer.
April 14, 2022
Brimonidine tartrate/timolol maleate combination eyedrop is used to treat elevated eye pressure in patients with ocular hypertension1 Ocular hypertension affects over 5% of all adults2; the eye does